癌症研究
免疫抑制
免疫疗法
PI3K/AKT/mTOR通路
医学
抗体
PD-L1
免疫系统
细胞凋亡
免疫学
化学
生物化学
作者
Guang-Lin Song,Yanling Lü,Li-na Tang,Min Li,Jie Yin,Hongming Chen,Jun-Da Ling
标识
DOI:10.1080/08923973.2021.1990315
摘要
Our results provide a scientific basis to develop combination therapies involving anti-PD-L1 and PI3K inhibitors to improve responses in patients with esophageal cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI